ARCHIVES

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Liver Transplant Associated With 67% 5-Year Survival

February 23, 2007

DCT Board to Study Modifications Of Existing Cooperative Group System

June 13, 1986

NCI To Cut Smoking Intervention Study By 20%, Says Chemoprevention Accrual Has Priority

November 6, 1992

Congressman Obey Attacks NCI for Not Supporting Basic Research

January 23, 1976

AGS-003 Increased Survival In Combination with Sunitinib

February 24, 2012

L.A. County Nears Crucial Decision On Construction Funds

January 7, 1977